Ann: MDR Jun-17 Quarterly Report & 4C, page-2

•Q4 operating cash inflow was $1.4m up 481% on same quarter prior year

• Revenue of $1.43 million, an increase of 12% on the March 2017 quarter ($1.27m) and 367% ahead of the June 2016 quarter

• FY17 total operating cash inflow was $5.02m ($5.5m including R&D Rebate) and FY17 Operating revenue totalled $4.24m (excludes R&D Rebate), 210% higher than FY16

• Positive operational performance and growth across key metrics: o Over 830,000 users on the MedAdvisor platform, an increase of 17% on the March 2017 quarter o Expanded the MedAdvisor Pharmacy Network, to over 2,600+, with MedAdvisor now providing its platform to all of Discount Drug Stores (DDS) nationwide

• Dr David Chatterton (ex Aconex Ltd CTO – ASX:ACX) appointed Chief Technology Officer ahead of next phase of growth • New pharmacy software platform developed “PlusOne” that will provide additional pharmacy services and expand revenue opportunities for MedAdvisor and network pharmacy customers